News

SeaStar Medical Holding Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 12, 2026, reporting financial results for the three and nine months ended on that date.

Theriva Biologics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, disclosing a continued operating loss alongside a significant reduction in operating expenses compared to the prior-year period.

CorMedix Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 12, 2026, reporting a net loss of $14.7 million for the third quarter and net income of $49.9 million for the nine-month …

RUM Group Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing share counts across three common stock classes and providing forward-looking risk factors tied to its recent business combination with Northern Data AG and …

Presurance Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 12, 2026, reporting a third-quarter net loss alongside a nine-month net income driven in part by a change in fair value of contingent considerations.

Alliance Entertainment Holding Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, reporting results for its fiscal first quarter.

Boost Run Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, and reporting significant balance sheet growth alongside an accumulated deficit of $110.3 million.